Review
Oct 2026
PSMA-targeted radioligand therapy in prostate cancer: evidence hierarchy, platform maturity of ¹⁷⁷Lu-PSMA-617, and the clinical differentiation challenge for emerging radionuclides.
En-Ting Lin
· Annals of Nuclear Medicine · 0 citations